STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Pharmaceuticals
chemistry-2

Telomir Pharmaceuticals Unveils Groundbreaking Progeria Treatment in Preclinical Study

byLuca Blaumann
January 7, 2025
in Pharmaceuticals, Small-Cap
Reading Time: 3 mins read
Share on TwitterShare on LinkedIn

Novel Therapy Shows Promise in Restoring Lifespan and Addressing Accelerated Aging

Telomir Pharmaceuticals (TELO), a leader in age-reversal science, has announced promising results from a preclinical study of Telomir-1, a potential therapy targeting the accelerated aging associated with progeria. Conducted in collaboration with Nagi Bioscience SA, the study utilized C. elegans (nematode) models to demonstrate that Telomir-1 effectively restores shortened lifespan and normalizes aging processes.

Key Findings from the Study

The study focused on nematodes with a mutation in the wrn-1 gene, analogous to the human gene implicated in Werner Syndrome, a form of progeria. These mutated nematodes showed significantly reduced lifespans compared to normal counterparts. However, treatment with Telomir-1 restored their longevity to levels comparable to non-mutated specimens. The therapy also improved physiological markers such as movement velocity and tail amplitude, extending healthy lifespan alongside overall longevity.

Dr. Laurent Mouchiroud, Co-founder and CSO of Nagi Bioscience, emphasized the therapy’s transformative potential: “These findings underscore Telomir-1’s ability to counter the decline observed in untreated populations, offering new hope for age-related conditions.”

Understanding Progeria and Accelerated Aging

Progeria, or Hutchinson-Gilford Progeria Syndrome, is a rare genetic disorder causing rapid aging in children. Affecting fewer than 400 individuals globally, the condition leads to severe complications, including cardiovascular issues and premature death.

At its core, progeria results from the accumulation of progerin, a defective protein that accelerates telomere shortening and disrupts cellular processes. Telomeres, the protective caps of chromosomes, naturally shorten with age, but this process is dramatically hastened in progeria, causing widespread cellular dysfunction.

Telomir-1: A Novel Approach

Telomir-1 addresses cellular dysfunction by regulating metal imbalances, reducing oxidative stress, and preventing telomere shortening. Key features of the therapy include:

  • Iron Regulation: Mitigating iron overload to reduce oxidative stress and prevent ferroptosis, a form of cell death linked to accelerated aging.
  • Copper Balancing: Addressing copper imbalances to improve organ function and metabolism, targeting conditions like Wilson’s disease.

These mechanisms support cellular health and longevity, making Telomir-1 a promising candidate for addressing progeria and other age-related diseases.

Broader Applications and Future Research

Beyond progeria, Telomir-1 has shown potential in reversing biological aging, improving insulin resistance in Type 2 diabetes, and regulating copper metabolism in Wilson’s disease.

“Our research validates Telomir-1’s ability to tackle aging at its root,” said Erez Aminov, Chairman and CEO of Telomir. “This therapy represents a novel pathway to treating progeria while exploring broader applications in aging-related conditions.”

Telomir is now preparing for in vitro studies using human progeria cell lines, aiming to further establish Telomir-1’s efficacy in restoring cellular health and normalizing aging processes. This breakthrough could pave the way for transformative therapies addressing the fundamental causes of aging.

Read original press release here

You might like this article:Nvidia Unveils AI and Gaming Innovations at CES 2025

Tags: GrowthLongevityMoversNewsStock MarketTELOTelomir Pharmaceuticals
Previous Post

Nvidia Unveils AI and Gaming Innovations at CES 2025

Next Post

Uber and NVIDIA Partner to Accelerate Autonomous Driving with AI-Powered Solutions

Related Posts

opthalmology

Telomir Pharmaceuticals Reports Breakthrough in Oral Therapy for Vision Loss

byLiliana Vida
May 29, 2025
0

Telomir-1 reverses retinal degeneration and restores vision in advanced AMD zebrafish model Telomir Pharmaceuticals (TELO) announced a major preclinical breakthrough...

Telomir Pharmaceuticals Secures $3M Premium Equity Investment to Advance Rare Disease Program

byLuca Blaumann
May 21, 2025
0

Insider-Led Funding with No Warrants Strengthens Balance Sheet Ahead of IND Submission for Telomir-1 Telomir Pharmaceuticals (TELO), a biotech innovator...

Institutional Interest In Telomir Pharmaceuticals

byLiliana Vida
May 13, 2025
0

Telomir Pharmaceuticals (TELO) has caught the attention of institutional investors, with JPMorgan Chase & Co. (JPM) significantly increasing its position...

Next Post

Uber and NVIDIA Partner to Accelerate Autonomous Driving with AI-Powered Solutions

Latest News

Marvell Projects Strong Q2 Growth on AI Chip Demand Surge

Nvidia Surges as AI Momentum Outweighs China Setbacks in Q1 Earnings

Telomir Pharmaceuticals Reports Breakthrough in Oral Therapy for Vision Loss

Macy’s Beats Q1 Estimates But Cuts 2025 Outlook Amid Retail Headwinds

Bitcoin Smashes Through $111K Amid Regulatory Optimism and Institutional Demand

Based on Your Interest

Pharmaceuticals

Telomir Pharmaceuticals Secures $3M Premium Equity Investment to Advance Rare Disease Program

May 21, 2025
tesla-2
Mega-Cap

Elon Musk Confirms Tesla and xAI to Continue Buying AI Chips from Nvidia and AMD

May 21, 2025
Aerospace & Defense

KULR Expands Bitcoin Treasury to $78 Million, Strengthens Crypto-Centric Financial Strategy

May 20, 2025

Recommended

Internet

Reddit Stock: Undervalued Gem in the Social Media Landscape

May 20, 2025
Large-Cap

AMD to Sell ZT Systems Manufacturing Business to Sanmina in $3 Billion Deal

May 19, 2025
Large-Cap

Dick’s Sporting Goods to Acquire Foot Locker in $2.4 Billion Deal

May 16, 2025
Large-Cap

AMD Expands Stock Buyback Program to $10 Billion Amid Strong Financial Confidence

May 14, 2025
Brokerages

Coinbase Surges After Landmark S&P 500 Inclusion

May 13, 2025
Stoxpo

Follow us on social media:

Highlights

  • Marvell Projects Strong Q2 Growth on AI Chip Demand Surge
  • Nvidia Surges as AI Momentum Outweighs China Setbacks in Q1 Earnings
  • Telomir Pharmaceuticals Reports Breakthrough in Oral Therapy for Vision Loss
  • Macy’s Beats Q1 Estimates But Cuts 2025 Outlook Amid Retail Headwinds
  • Bitcoin Smashes Through $111K Amid Regulatory Optimism and Institutional Demand

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

investing

Marvell Projects Strong Q2 Growth on AI Chip Demand Surge

May 29, 2025
semiconductor-2

Nvidia Surges as AI Momentum Outweighs China Setbacks in Q1 Earnings

May 29, 2025
opthalmology

Telomir Pharmaceuticals Reports Breakthrough in Oral Therapy for Vision Loss

May 29, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?